TuHURA Biosciences, Inc.
HURA
$2.16
-$0.43-16.60%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -13.09% | -12.77% | -27.31% | -80.88% | -37.63% |
| Total Depreciation and Amortization | 66.67% | 27.84% | -26.80% | -62.36% | -58.89% |
| Total Amortization of Deferred Charges | -- | 180.86% | -- | -- | -- |
| Total Other Non-Cash Items | 96.27% | -77.68% | 684.44% | 125.99% | 341.77% |
| Change in Net Operating Assets | -37.62% | -78.36% | -523.71% | 310.93% | -23.12% |
| Cash from Operations | 6.87% | -113.73% | -243.39% | -23.34% | -23.58% |
| Capital Expenditure | -14.29% | -30.37% | -- | 84.66% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 100.00% | 100.00% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 95.76% | 96.61% | 100.00% | -328.77% | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 1,387.50% | 44,763.04% | -11.90% | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00% | -- | -- | -- | -- |
| Other Financing Activities | 85.74% | 75.18% | 58.04% | 72.68% | -285.60% |
| Cash from Financing | 1,403.16% | 285.07% | -66.44% | -32.85% | -111.83% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 141.60% | 113.29% | -179.83% | -70.79% | -908.20% |